SyntaxBio (Chicago, IL) is developing a proprietary CRISPR/Cas9 based, genetic programming platform technology that converts cells into biological computers using DNA based instructions that read like lines of code. SyntaxBio is a genetic platform that can program populations of cells without the need for consistent external intervention.
Investors 1
| Date | Name | Website |
| - | XLerateHea... | xleratehea... |